BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update

  August 12, 2025

   · 

  12 min read
• Press Releases

  Harvard Bioscience Announces Second Quarter 2025 Financial Results

  August 12, 2025

   · 

  12 min read
• Press Releases

  Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas

  August 12, 2025

   · 

  6 min read
• Press Releases

  Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update

  August 12, 2025

   · 

  18 min read
• Press Releases

  Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome

  August 12, 2025

   · 

  14 min read
• Press Releases

  Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update

  August 12, 2025

   · 

  15 min read
• Press Releases

  Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results

  August 12, 2025

   · 

  13 min read
• Press Releases

  Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025

  August 12, 2025

   · 

  10 min read
• Press Releases

  Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030

  August 12, 2025

   · 

  9 min read
• Press Releases

  FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response

  August 12, 2025

   · 

  3 min read